Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.54 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.37 |
| ▸ | RPS6KA5 | O75582 | 2/20 | 0.36 |
| ▸ | AXL | P30530 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22092691 | 0.75 | NPC1 (0.68) | EPAS1KMT2APOLBNPC1MAPT | |
| SCHEMBL3078778 | 0.74 | ENPP2 (0.58) | ENPP2EPAS1KDM4EKCNJ1KCNH2 | |
| SCHEMBL14666982 | 0.73 | ENPP2 (0.44) | ENPP2EPAS1KMT2AKCNJ1KCNH2 | |
| SCHEMBL13610351 | 0.71 | ALDH1A1 (0.48) | ENPP2EPAS1KDM4EKMT2AKCNJ1 | |
| SCHEMBL298552 | 0.70 | ENPP2 (0.54) | ENPP2EPAS1KMT2AKCNJ1KCNH2 | |
| SCHEMBL13928717 | 0.70 | ENPP2 (0.54) | ENPP2EPAS1KDM4EKCNJ1KCNH2 | |
| SCHEMBL3038439 | 0.70 | ENPP2 (0.54) | ENPP2EPAS1KCNJ1KCNH2POLB | |
| SCHEMBL1358998 | 0.70 | ENPP2 (1.00) | ENPP2KDM4EKMT2AKCNJ1KCNH2 | |
| SCHEMBL3191645 | 0.70 | ENPP2 (0.54) | ENPP2KDM4EKMT2AKCNJ1KCNH2 | |
| SCHEMBL2708419 | 0.70 | ENPP2 (0.54) | ENPP2EPAS1KDM4EKMT2AKCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071782-A | Use of donor-acceptor polymers based on fluorobenzooxadiazoles in electronics and photonics | 香港科技大学 | 2018-12-21 | — | — | CN | claimed |
| US-20180355099-A1 | Fluorinated Benzoxadiazole-Based Donor-Acceptor Polymers for Electronic and Photonic Applications | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2018-12-13 | — | — | US | claimed |
| US-20250327100-A1 | Strain of Pseudomonas Putida Genetically Modified to Express a Benzalacetone Reductase | BGENE GENETICS (FR) | 2025-10-23 | — | — | US | disclosed |
| US-20240368173-A1 | TRICYCLIC GPR65 MODULATORS | Pathios Therapeutics Limited (GB) | 2024-11-07 | — | — | US | disclosed |
| US-12075697-B2 | Inert solution-processable molecular chromophores for organic electronic devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-27 | — | — | US | disclosed |
| US-12075697-B2 | Inert solution-processable molecular chromophores for organic electronic devices | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-27 | — | — | US | disclosed |
| US-20220223797-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-14 | — | — | US | disclosed |
| US-20220223797-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-14 | — | — | US | disclosed |
| US-20220223797-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-14 | — | — | US | disclosed |
| CN-110003234-B | Dithienobenzo-isoaromatic-based hetero-condensed ring D (A-Ar)2Conjugated compound and application thereof | 常州大学 | 2021-08-24 | — | — | CN | disclosed |
| EP-2828902-B1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | UNIV CALIFORNIA (US) | 2021-08-04 | — | — | EP | disclosed |
| US-20130247989-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-09-26 | — | — | US | disclosed |
| WO-2013142850-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-09-26 | — | — | WO | disclosed |
| US-20130026459-A1 | POLYMER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130026459-A1 | POLYMER COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-31 | — | — | US | disclosed |
| EP-0641785-B1 | TRIAZOLYLATED TERTIARY AMINE COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMA CO LTD (JP) | 1999-10-27 | — | — | EP | disclosed |
| EP-0640595-B1 | SUBSTITUTED TERTIARY AMINO COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMA CO LTD (JP) | 1999-03-24 | — | — | EP | disclosed |
| US-5674886-A | AROMATASE INHIBITOR; BREAST CANCER; UROGENITAL DISORDERS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1997-10-07 | — | — | US | disclosed |
| EP-0641785-A1 | TRIAZOLYLATED TERTIARY AMINE COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1995-03-08 | — | — | EP | disclosed |
| EP-0640595-A1 | NOVEL SUBSTITUTED TERTIARY AMINO COMPOUND OR SALT THEREOF | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1995-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368173-A1 | TRICYCLIC GPR65 MODULATORS | GPR65, GPR3, NR1H2 | ENPP2 696/4885EPAS1 1790/4885KDM4E 3978/4885 |
| US-20130026459-A1 | POLYMER COMPOUND | SCO2, RER1, CRY1 | ENPP2 4097/4885EPAS1 2825/4885KDM4E 3371/4885 |
| US-20220223797-A1 | INERT SOLUTION-PROCESSABLE MOLECULAR CHROMOPHORES FOR ORGANIC ELECTRONIC DEVICES | KMO, TDO2, HTR3D | ENPP2 4764/4885EPAS1 3478/4885KDM4E 3110/4885 |
| US-20180355099-A1 | Fluorinated Benzoxadiazole-Based Donor-Acceptor Polymers for Electronic and Photonic Applications | FTO, PPOX, FOXO3 | ENPP2 3781/4885EPAS1 4810/4885KDM4E 126/4885 |
| US-12075697-B2 | Inert solution-processable molecular chromophores for organic electronic devices | KMO, TDO2, HTR3D | ENPP2 4764/4885EPAS1 3478/4885KDM4E 3110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.